PF-07059013
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07059013, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants [Phase 1]